The United Laboratories International Holdings Limited (3933.HK)
HKD 13.94
(0.29%)
HKD 13.94
(0.29%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 6.33 Billion CNY | 27.49% |
| 2022 | 4.96 Billion CNY | 18.0% |
| 2021 | 4.21 Billion CNY | 10.64% |
| 2020 | 3.8 Billion CNY | 5.11% |
| 2019 | 3.62 Billion CNY | 18.65% |
| 2018 | 3.05 Billion CNY | 22.17% |
| 2017 | 2.49 Billion CNY | 15.52% |
| 2016 | 2.16 Billion CNY | -12.82% |
| 2015 | 2.48 Billion CNY | -3.93% |
| 2014 | 2.58 Billion CNY | 25.38% |
| 2013 | 2.05 Billion CNY | 20.8% |
| 2012 | 1.7 Billion CNY | 15.18% |
| 2011 | 1.48 Billion CNY | -32.37% |
| 2010 | 2.18 Billion CNY | 37.03% |
| 2009 | 1.59 Billion CNY | 26.88% |
| 2008 | 1.25 Billion CNY | 11.44% |
| 2007 | 1.12 Billion CNY | 53.0% |
| 2006 | 738.28 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 3.34 Billion CNY | 0.0% |
| 2023 Q2 | 3.21 Billion CNY | 0.0% |
| 2023 Q4 | 3.12 Billion CNY | 0.0% |
| 2023 FY | 6.33 Billion CNY | 27.49% |
| 2022 Q2 | 2.25 Billion CNY | 0.0% |
| 2022 Q4 | 2.71 Billion CNY | 0.0% |
| 2022 FY | 4.96 Billion CNY | 18.0% |
| 2021 FY | 4.21 Billion CNY | 10.64% |
| 2021 Q4 | 2.11 Billion CNY | 0.0% |
| 2021 Q2 | 2.09 Billion CNY | 0.0% |
| 2020 FY | 3.8 Billion CNY | 5.11% |
| 2020 Q2 | 1.79 Billion CNY | 0.0% |
| 2020 Q4 | 2 Billion CNY | 0.0% |
| 2019 Q2 | 1.72 Billion CNY | 0.0% |
| 2019 Q4 | 1.9 Billion CNY | 0.0% |
| 2019 FY | 3.62 Billion CNY | 18.65% |
| 2018 Q2 | 1.58 Billion CNY | 0.0% |
| 2018 Q4 | 1.46 Billion CNY | 0.0% |
| 2018 FY | 3.05 Billion CNY | 22.17% |
| 2017 FY | 2.49 Billion CNY | 15.52% |
| 2017 Q2 | 1.18 Billion CNY | 0.0% |
| 2017 Q4 | 1.31 Billion CNY | 0.0% |
| 2016 Q4 | 1.07 Billion CNY | 0.0% |
| 2016 Q2 | 1.08 Billion CNY | 0.0% |
| 2016 FY | 2.16 Billion CNY | -12.82% |
| 2015 Q4 | 1.1 Billion CNY | 0.0% |
| 2015 FY | 2.48 Billion CNY | -3.93% |
| 2015 Q2 | 1.31 Billion CNY | 0.0% |
| 2014 FY | 2.58 Billion CNY | 25.38% |
| 2014 Q4 | 1.34 Billion CNY | 0.0% |
| 2014 Q2 | 1.23 Billion CNY | 0.0% |
| 2013 Q4 | 1.16 Billion CNY | 0.0% |
| 2013 Q2 | 908.13 Million CNY | 0.0% |
| 2013 FY | 2.05 Billion CNY | 20.8% |
| 2012 Q3 | 426.2 Million CNY | -0.0% |
| 2012 FY | 1.7 Billion CNY | 15.18% |
| 2012 Q4 | 515.27 Million CNY | 20.9% |
| 2012 Q1 | 426.2 Million CNY | -0.0% |
| 2012 Q2 | 426.2 Million CNY | 0.0% |
| 2011 Q1 | 370.02 Million CNY | 0.0% |
| 2011 FY | 1.48 Billion CNY | -32.37% |
| 2011 Q4 | 426.2 Million CNY | 15.18% |
| 2011 Q3 | 370.02 Million CNY | 0.0% |
| 2011 Q2 | 370.02 Million CNY | 0.0% |
| 2010 Q1 | 547.13 Million CNY | -0.0% |
| 2010 FY | 2.18 Billion CNY | 37.03% |
| 2010 Q4 | 370.02 Million CNY | -32.37% |
| 2010 Q3 | 547.13 Million CNY | -0.0% |
| 2010 Q2 | 547.13 Million CNY | 0.0% |
| 2009 Q3 | 399.28 Million CNY | 0.0% |
| 2009 Q2 | 399.28 Million CNY | 0.0% |
| 2009 Q1 | 399.28 Million CNY | 0.0% |
| 2009 FY | 1.59 Billion CNY | 26.88% |
| 2009 Q4 | 547.13 Million CNY | 37.03% |
| 2008 FY | 1.25 Billion CNY | 11.44% |
| 2008 Q4 | 399.28 Million CNY | 26.88% |
| 2008 Q3 | 314.69 Million CNY | -0.0% |
| 2008 Q1 | 314.69 Million CNY | -0.0% |
| 2008 Q2 | 314.69 Million CNY | 0.0% |
| 2007 Q2 | 282.39 Million CNY | 0.0% |
| 2007 Q1 | 282.39 Million CNY | -0.0% |
| 2007 FY | 1.12 Billion CNY | 53.0% |
| 2007 Q4 | 314.69 Million CNY | 11.44% |
| 2007 Q3 | 282.39 Million CNY | -0.0% |
| 2006 Q4 | 282.39 Million CNY | 53.0% |
| 2006 Q3 | 184.57 Million CNY | -0.0% |
| 2006 Q1 | 184.57 Million CNY | -0.0% |
| 2006 FY | 738.28 Million CNY | 0.0% |
| 2006 Q2 | 184.57 Million CNY | 0.0% |
| 2005 Q4 | 184.57 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 167.43 Million HKD | -3683.438% |
| Grand Pharmaceutical Group Limited | 6.52 Billion HKD | 2.9% |
| Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -21912.012% |
| Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | -1504.516% |
| Qianhai Health Holdings Limited | -35.6 Million HKD | 17892.987% |
| Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | -1049.05% |
| Essex Bio-Technology Limited | 1.53 Billion HKD | -311.542% |
| Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | -1244.143% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -2824.279% |
| SSY Group Limited | 3.48 Billion HKD | -81.557% |
| JBM (Healthcare) Limited | 319.41 Million HKD | -1883.256% |
| Jacobson Pharma Corporation Limited | 620.47 Million HKD | -920.966% |
| China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 85.392% |